ArticleBioMed research international2022
Breast Cancer Screening in Low-Income Countries: A New Program for Downstaging Breast Cancer in Tanzania.
Article in BioMed research international, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 15 citations in OpenAlex.
- Clinical features, diagnosis, and referral of women with breast abnormalities in primary health care settings in rural Ethiopia: a retrospective record analysis.BMC primary care · 2026Article
- Article
- Individual-level and community-level factors associated with breast cancer screening among women of reproductive age in Tanzania: a multilevel analysis of the 2022 Tanzania Demographic and Health Survey.BMJ public health · 2026Article
- Article
- Factors associated with the uptake of clinical breast examination for early detection of breast cancer: interaction analysis of the 2022 Tanzania Demographic and Health Survey and Malaria Indicator Survey.BMJ public health · 2025Article
- The Changing Landscape of Cervical Cancer in Africa: Opportunities for Patient, Public, and Professional Education.Journal of cancer education : the official journal of the American Association for Cancer Education · 2024Article
- Strengthening uptake of breast cancer screening services in Tanzania; re-visiting the breast cancer screening messages.BMC cancer · 2024Article
- Multi-level barriers to early detection of breast cancer among rural midlife women in Tanzania: A qualitative case study.PloS one · 2024Article
- Facilitators and barriers to decision-making for hospital treatment among patients diagnosed with breast cancer in Dar es Salaam, Tanzania: A qualitative urban-based study.PLOS global public health · 2024Article
- The impact of in-house pathology services on downstaging cervical cancer in Tanzania over an 18-year period.Cancer causes & control : CCC · 2024Article
- Breast Cancer Screening among Young Women in Tanzania: Findings from the 2022 Demographic and Health Survey.Cancer control : journal of the Moffitt Cancer CenterArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 3 institutions in 2 countries.
Funding
Abstract
Background: Most breast cancer diagnoses in Tanzania are in advanced stages. The Ocean Road Cancer Institute (ORCI) established a new breast cancer screening program in 2014 to reduce advanced-stage diagnoses. This study is aimed at describing the screening program's referral process and at identifying patient and health system factors that contribute to patients completing diagnostic testing referrals. Methods: Six-hundred and forty patients were included in the study. Testing types, outcomes, and date of diagnostic results were abstracted from records at ORCI and Muhimbili National Hospital (MNH) to determine the proportion of testing completed and the duration between initial referrals and diagnostic tests. Prediction of completion of diagnostic testing was investigated in logistic regression. Results: Of the patients who received referrals for further testing, fifty-two percent completed the recommended ultrasound (USS), mammography (MMG), and fine-needle aspiration cytology (FNAC). Only 33.0% of patients completed the recommended MMG referrals compared to 55.0% for ultrasound and 68.7% for FNAC. The average number of days between initial screening and results was 42 days for MMG, 20 days for USS, and 18 days for FNAC. Significant predictors for completing referrals for USS, FNAC, and MMG included age < 44 and >55 years, presenting with symptoms at the initial appointment, and education. The odds of completing an USS was 3.03 (95% CI, 1.65-5.64) for patients 25-34, 2.27 (95% CI, 1.17-4.48) for patients 35-44, and 4.41 (95% CI, 1.66-10.11) for patients older than 55 years compared to the reference group (age 19-24). The presence of symptoms at the initial appointment was a significant predictor of FNAC. The odds of completing an FNAC was 1.55 (95% CI, 1.02-3.72) for symptomatic compared to nonsymptomatic patients. Education was a significant predictor of MMG. The odds of receiving MMG was 4.29 (95% CI, 1.05-21.00) for patients with tertiary education or higher compared to primary education or lower. Possession of health insurance for treatment and living in Dar es Salaam were not significant predictors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.